Amgen Inc. buy BMO Capital Markets
Start price
03.12.25
/
50%
€288.65
Target price
03.12.26
-
Performance (%)
5.39%
Price
02.04.26
€301.70
Summary
This prediction is currently active. With a performance of 5.39%, the BUY prediction by BMO_Capital_Markets for Amgen Inc. is trending in the right direction. A total of €2.52 was paid as dividends for this prediction. This prediction currently runs until 03.12.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -1.758% | -1.758% |
| iShares Core DAX® | 2.489% | -5.941% |
| iShares Nasdaq 100 | 1.649% | -2.462% |
| iShares Nikkei 225® | 0.555% | -7.597% |
| iShares S&P 500 | 1.347% | -2.943% |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Ratings data for AMGN provided by MarketBeat